My Market Wizard

BIO-RAD LABORATORIES, INC. 8-K Analysis & Summary – 2/21/2025

⚠️This is not investment advice.

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️

Bio-Rad Laboratories, Inc.

Filing date:

02/21/2025

TLDR:

Bio-Rad Laboratories provides an update on Sartorius AG’s financial results for the year ended December 31, 2024, as disclosed by Sartorius AG.

ELI5:

Bio-Rad is sharing an update about its investment in another company called Sartorius AG. This update is about Sartorius AG’s financial performance for the past year.

Accession #:

0000012208-25-000009

Published on

Analyst Summary

  • Sartorius AG’s sales revenue for the year ended December 31, 2024 was €3,380.7 million.
  • Gross profit on sales for Sartorius AG was €1,524.4 million.
  • Earnings before interest and taxes (EBIT) for Sartorius AG was €392.6 million.
  • Net profit for Sartorius AG was €137.4 million.
  • Cash flow from operating activities for Sartorius AG was €976.2 million.

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️